Innovus Pharmaceuticals, Inc. (QB) Stock Price - INNV

Best deals to access real time data!
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Innovus Pharmaceuticals, Inc. (QB) INNV Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.029348 +24.56% 0.148848 0.18 0.125 0.135 0.1195 15:57:16
Bid Price Ask Price Spread Spread % News
0.147 0.1494 0.0024 1.61% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
852 7,441,083 $ 0.1515 $ 1.13M 829.69k 0.08 - 0.39
Last Trade Time Type Quantity Stock Price Currency
15:57:16 10,000 $0.15 USD

Innovus Pharmaceuticals, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 24.48M 164.43M $ -13.7M - -1.79 108.53M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Innovus Pharmaceuticals, Inc. (QB) News

Latest INNV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INNV Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.10.180.0980.1124488k7M928k0.04884848.85%
1 Month0.0850.180.080.0998105k7M730k0.06384875.12%
3 Months0.08680.180.0780.0940101k7M783k0.06204871.48%
6 Months0.1250.180.0780.096245k7M572k0.02384819.08%
1 Year0.1980.390.0780.119345k19M729k-0.049152-24.82%
3 Years0.23990.6630.00010.2007019M543k-0.091052-37.95%
5 Years0.381.160.00010.2066019M355k-0.231152-60.83%

Innovus Pharmaceuticals, Inc. (QB) Description

Headquartered in San Diego, Innovus Pharma is an emerging leader in OTC and consumer products for men's and women's health and vitality. The Company generates revenues from its lead products Zestra for female arousal and EjectDelay for premature ejaculation and has a total of five marketed products in this space, including Sensum+ for the indication of reduced penile sensitivity, (for sales outside the U.S. only), Zestra Glide, Vesele for promoting sexual and cognitive health, Androferti (in the US and Canada) to support overall male reproductive health and sperm quality and FlutiCare OTC for Allergic Rhinitis. Innovus Pharma's mission is to in-license, acquire or develop over-the-counter and consumer healthcare products designed for in-home treatment of medical conditions and ailments to help people take care of themselves and their families in order to live healthy lives.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.